Reuters logo
BRIEF-FDA grants Roche label extension for cobas EGFR mutation test
September 29, 2016 / 5:20 AM / a year ago

BRIEF-FDA grants Roche label extension for cobas EGFR mutation test

Sept 29 (Reuters) - Roche Holding AG

* FDA grants Roche label extension for cobas egfr mutation test v2 for use with plasma as a companion diagnostic for Tagrisso

* FDA approved a label extension of cobas egfr mutation test v2 for use with plasma samples as a companion diagnostic for Astra Zeneca’s non-small cell lung cancer (nsclc) therapy Tagrisso Source text for Eikon: Further company coverage: (Reporting By Michael Shields)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below